20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 324, Issue 1, 2008, Pages 103-110

  Ishizuka, Tsuneo ^a   Cheng, Jennifer ^a   Singh, Harpreet ^a   Vitto, Marco D ^a   Manthati, Vijay L ^b   Falck, John R ^b   Laniado Schwartzman, Michal ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 20 HYDROXYICOSATETRAENOIC ACID; 3 NITROTYROSINE; 8 EPI ISOPROSTANE PROSTAGLANDIN F2ALPHA; ADENOVIRUS VECTOR; ADENOVIRUS VECTOR 4A1; ADENOVIRUS VECTOR 4A2; ADENOVIRUS VECTOR GFP; CHEMOTACTIC FACTOR; CYTOCHROME P450 4A1; CYTOCHROME P450 4A2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROCIRCULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ALKANE 1-MONOOXYGENASE; CELL LINE; CYTOKINES; DINOPROST; DINOPROSTONE; ENDOTHELIAL CELLS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; I-KAPPA B KINASE; INTERCELLULAR ADHESION MOLECULE-1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; TYROSINE;

EID: 37349011542     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.130336     Document Type: Article

References (40)

1. Amaral SL, Maier KG, Schippers DN, Roman RJ, and Greene AS (2003) CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol 284:H1528-H1535.
2. Anrather J, Racchumi G, and Iadecola C (2006) NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 281:5657-5667.
3. Barden A, Zilkens RR, Croft K, Mori T, Burke V, Beilin LJ, and Puddey IB (2007) A reduction in alcohol consumption is associated with reduced plasma F(2)-isoprostanes and urinary 20-HETE excretion in men. Free Radic Biol Med 42: 1730-1735.
4. Chen P, Guo M, Wygle D, Edwards PA, Falck JR, Roman RJ, and Scicli AG (2005) Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am J Pathol 166:615-624.
5. Chen Y, Medhora MM, Falck JR, Pritchard KA, and Jacobs ER (2006) Mechanisms of activation of eNOS by 20-hydroxyeicosatetraenoic acid and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 291: L369-L377.
6. De Caterina R, Liao JK, and Libby P (2000) Fatty acid modulation of endothelial activation. Am J Clin Nutr 71:213S-223S.
7. Edgell CJ, McDonald CC, and Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 80:3734-3737.
8. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, and Busse R (2001) Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88:44-51.
9. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, et al. (2000) Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87:60-65.
10. Guo AM, Arbab AS, Falck JR, Chen P, Edwards PA, Roman RJ, and Scicli AG (2007) Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 321:18-27.
11. Häcker H and Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006:re13.
12. Harder DR, Gebremedhin D, Narayanan J, Jefcote C, Falck JR, Campbell WB, and Roman R (1994) Formation and action of a P450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol Heart Circ Physiol 266:H2098-H2107.
13. Hennig B, Meerarani P, Ramadass P, Watkins BA, and Toborek M (2000) Fatty acid-mediated activation of vascular endothelial cells. Metabolism 49:1006-1013.
14. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, and Roman RJ (1996) Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol Regul Integr Comp Physiol 270:R217-R227.
15. Jiang M, Mezentsev A, Kemp R, Byun K, Falck JR, Miano JM, Nasjletti A, Abraham NG, and Laniado-Schwartzman M (2004) Smooth muscle-specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels. Circ Res 94:167-174.
16. Kabe Y, Ando K, Hirao S, Yoshida M, and Handa H (2005) Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7:395-403.
17. Kang JS, Yoon YD, Han MH, Han SB, Lee K, Lee KH, Park SK, and Kim HM (2006) Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-α-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-κB/Rel signaling pathways. Mol Pharmacol 69:941-949.
18. Karin M (1999) The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274:27339-27342.
19. Karin M and Delhase M (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12:85-98.
20. Kinlay S, Libby P, and Ganz P (2001) Endothelial function and coronary artery disease. Curr Opin Lipidol 12:383-389.
21. Kroetz DL and Xu F (2005) Regulation and inhibition of arachidonic acid omegahydroxylases and 20-HETE formation. Annu Rev Pharmacol Toxicol 45:413-438.
22. Marji JS, Wang MH, and Laniado-Schwartzman M (2002) Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Am J Physiol Renal Physiol 283:F60-F70.
23. Miyata N and Roman RJ (2005) Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41:175-193.
24. Monaco C and Paleolog E (2004) Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61:671-682.
25. Montuschi P, Barnes PJ, and Roberts LJ 2nd (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791-1800.
26. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, and Malik KU (1998) 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin- dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci U S A 95:12701-12706.
27. Muthalif MM, Benter IF, Khandekar Z, Gaber L, Estes A, Malik S, Parmentier JH, Manne V, and Malik KU (2000a) Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 35:457-463.
28. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, Parmentier JH, Estes A, and Malik KU (2000b) Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 36:604-609.
29. Nguyen X, Wang MH, Reddy KM, Falck JR, and Schwartzman ML (1999) Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol Regul Integr Comp Physiol 276:R1691-R1700.
30. Okita RT and Okita JR (2001) Cytochrome P450 4A fatty acid omega hydroxylases. Curr Drug Metab 2:265-281.
31. Randriamboavonjy V, Busse R, and Fleming I (2003) 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41:801-806.
32. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, and Schwartzman ML (1989) Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243:388-390.
33. Sarkis A and Roman RJ (2004) Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr Drug Metab 5:245-256.
34. Singh H, Cheng J, Deng H, Kemp R, Ishizuka T, Nasjletti A, and Schwartzman ML (2007) Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 50:123-129.
35. Stec D, Gannon KP, Beaird JS, and Drummond HA (2007) 20- Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells. Cell Physiol Biochem 19:121-128.
36. Thannickal VJ and Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279:L1005-L1028.
37. Wang JS, Singh H, Zhang F, Ishizuka T, Deng H, Kemp R, Wolin MS, Hintze TH, Abraham NG, Nasjletti A, et al. (2006) Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 98:962-969.
38. Ward NC, Puddey IB, Hodgson JM, Beilin LJ, and Croft KD (2005) Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic Biol Med 38:1032-1036.
39. Zhao Q and Lee FS (1999) Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β. J Biol Chem 274:8355-8358.
40. Zhu D, Zhang C, Medhora M, and Jacobs ER (2002) CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. J Appl Physiol 93:330-337.